Amicus Therapeutics Inc (NASDAQ:FOLD)

12.00
Delayed Data
As of 3:59pm ET
 -0.37 / -2.99%
Today’s Change
5.91
Today|||52-Week Range
12.76
+3.90%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 14.50, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +20.83% increase from the last price of 12.00.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$84.3M
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.39%
 
 
 
 
 
 
Growthannually 3.85%
 
 
 
 
 
 

Sales

Growthquarterly 4.48%
 
 
 
 
 
 
Growthannually 9.21%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.